Search Results

Article Topics

head and neck cancer (2)

Your search for Anil D’Cruz, MD matches 2 pages

Showing 1 - 2

By Anil D’Cruz, MD / 2015 ASCO Annual Meeting

Anil D'Cruz, MD, on Elective Neck Dissection in Node-Negative Early Oral Cancer

Anil D’Cruz, MD, of Tata Memorial Hospital, discusses results from his study that seem to resolve a 50-year-long debate on performing elective neck dissection at the time of primary surgery––a potentially practice-changing finding (Abstract LBA3).

head and neck cancer

By Alice Goodman / June 25, 2015

Elective Neck Dissection Beats Watch and Wait Approach in Early Oral Cancer

Elective neck dissection of node-negative early-stage oral cancer at the time of primary surgery improves overall survival and disease-free survival compared with therapeutic neck dissection (ie, therapeutic neck dissection at the time of nodal relapse, or “watch and wait” approach), according to a ...

Dec

Today In Oncology

Search Results

Article Topics

Your search for Anil D’Cruz, MD matches 2 pages

Anil D'Cruz, MD, on Elective Neck Dissection in Node-Negative Early Oral Cancer

Elective Neck Dissection Beats Watch and Wait Approach in Early Oral Cancer

Geriatric Assessment–Guided Multidisciplinary Care May Benefit Older Patients Undergoing HCT

Swedish Population Study of Risk-Adapted Screening Starting Ages for Relatives of Patients With Breast Cancer

Cardiovascular Disease Risk May Be Associated With Cancer Risk

Associations of Onctotype DX Breast Recurrence Score With Mortality Prediction and Difference Between Sexes

Quality of Life and Neurocognitive Function in Patients With Gliomas Treated With Temozolomide-Based Chemoradiotherapy

Emerging Alternatives in the Third-Line Setting for Metastatic HER2-Positive Breast Cancer

Promising New Treatments for Triple-Negative Breast Cancer: Immunotherapy and Other Targeted Therapies

Breast-Conserving Surgery and Partial-Breast Reirradiation in Patients With Ipsilateral Disease Recurrence

FDA Approves FoundationOne CDx as a Companion Diagnostic for Alpelisib/Fulvestrant Treatment in Breast Cancer

ASH 2019: PET-Directed Therapy for Early-Stage DLBCL